Rahim N, Wu Y, Sim M, Velaga A, Bonam S, Gopinath S
Pharmaceuticals (Basel). 2023; 16(1).
PMID: 36678607
PMC: 9867095.
DOI: 10.3390/ph16010110.
Lee J, Kim E, Kang M, Ryu J, Kim J, Shin E
BMB Rep. 2022; 55(12):609-614.
PMID: 36104259
PMC: 9813423.
Song H, Lee Y, Kim E, Cho C, Jung O, Lee D
Theranostics. 2021; 11(16):8092-8111.
PMID: 34335982
PMC: 8315060.
DOI: 10.7150/thno.58739.
Fan C, Liu N, Zheng D, Du J, Wang K
Cancer Manag Res. 2019; 11:6755-6764.
PMID: 31413629
PMC: 6660099.
DOI: 10.2147/CMAR.S199027.
Park S, Kim D, Wu G, Jung H, Park J, Kwon H
Onco Targets Ther. 2018; 11:8655-8672.
PMID: 30584324
PMC: 6284540.
DOI: 10.2147/OTT.S186606.
TM4SF5-Mediated Roles in the Development of Fibrotic Phenotypes.
Ryu J, Lee J
Mediators Inflamm. 2017; 2017:5108525.
PMID: 28458469
PMC: 5385246.
DOI: 10.1155/2017/5108525.
TM4SF1 Promotes Metastasis of Pancreatic Cancer via Regulating the Expression of DDR1.
Yang J, Zhang Y, He S, Li M, Cai X, Wang H
Sci Rep. 2017; 7:45895.
PMID: 28368050
PMC: 5377454.
DOI: 10.1038/srep45895.
Anti-metastatic effect of the TM4SF5-specific peptide vaccine and humanized monoclonal antibody on colon cancer in a mouse lung metastasis model.
Wu G, Kim D, Park B, Park S, Ha J, Kim T
Oncotarget. 2016; 7(48):79170-79186.
PMID: 27816969
PMC: 5346706.
DOI: 10.18632/oncotarget.13005.
A HLA-A2-restricted CTL epitope induces anti-tumor effects against human lung cancer in mouse xenograft model.
Sher Y, Lin S, Chen I, Liu H, Lin C, Chiang I
Oncotarget. 2015; 7(1):671-83.
PMID: 26621839
PMC: 4808025.
DOI: 10.18632/oncotarget.6400.
Role of TM4SF1 in regulating breast cancer cell migration and apoptosis through PI3K/AKT/mTOR pathway.
Sun Y, Xu Y, Xu J, Lu D, Wang J
Int J Clin Exp Pathol. 2015; 8(8):9081-8.
PMID: 26464650
PMC: 4583882.
TM4SF4 overexpression in radiation-resistant lung carcinoma cells activates IGF1R via elevation of IGF1.
Choi S, Kim S, Lee J, Cho E, Kim I
Oncotarget. 2014; 5(20):9823-37.
PMID: 25344917
PMC: 4259440.
DOI: 10.18632/oncotarget.2450.
Therapeutic effect of a TM4SF5-specific monoclonal antibody against colon cancer in a mouse model.
Kim Y, Kwon S, Wu G, Kim D, Park B, Park J
Oncotarget. 2014; 5(18):8402-15.
PMID: 25268742
PMC: 4226692.
DOI: 10.18632/oncotarget.2311.
Correlations between transmembrane 4 L6 family member 5 (TM4SF5), CD151, and CD63 in liver fibrotic phenotypes and hepatic migration and invasive capacities.
Kang M, Ryu J, Lee D, Lee M, Kim H, Nam S
PLoS One. 2014; 9(7):e102817.
PMID: 25033048
PMC: 4102591.
DOI: 10.1371/journal.pone.0102817.
Cross talk between the TM4SF5/focal adhesion kinase and the interleukin-6/STAT3 pathways promotes immune escape of human liver cancer cells.
Ryu J, Kang M, Lee M, Kim H, Nam S, Song H
Mol Cell Biol. 2014; 34(16):2946-60.
PMID: 24912675
PMC: 4135608.
DOI: 10.1128/MCB.00660-14.
Membrane Proteins Involved in Epithelial-Mesenchymal Transition and Tumor Invasion: Studies on TMPRSS4 and TM4SF5.
Kim S, Lee J
Genomics Inform. 2014; 12(1):12-20.
PMID: 24748857
PMC: 3990761.
DOI: 10.5808/GI.2014.12.1.12.
A high level of TM4SF5 is associated with human esophageal cancer progression and poor patient survival.
Wu Y, Huang Y, Xu Y, Sun Y, Yu D, Zhang X
Dig Dis Sci. 2013; 58(9):2623-33.
PMID: 23633159
DOI: 10.1007/s10620-013-2690-1.
Tetraspan TM4SF5-dependent direct activation of FAK and metastatic potential of hepatocarcinoma cells.
Jung O, Choi S, Jang S, Lee S, Lim S, Choi Y
J Cell Sci. 2012; 125(Pt 24):5960-73.
PMID: 23077174
PMC: 4074290.
DOI: 10.1242/jcs.100586.
Cell adhesion-dependent serine 85 phosphorylation of paxillin modulates focal adhesion formation and haptotactic migration via association with the C-terminal tail domain of talin.
Kwak T, Lee M, Ryu J, Choi Y, Kang M, Jeong D
J Biol Chem. 2012; 287(33):27499-509.
PMID: 22761432
PMC: 3431675.
DOI: 10.1074/jbc.M111.323360.